In the past several decades, we've seen medical innovations for just about every diagnosis. However, in the realm of brain cancer research — and especially glioblastoma research — treatment options have remained relatively static for decades. Thanks to NeOnc Technologies, that's hopefully about to change.
NeOnc was founded by Dr. Thomas Chen, Professor of Neurosurgery and Pathology and Director of Surgical Neuro-Oncology at the University of Southern California, and a foremost neurosurgeon.
